Fox Chase Cancer Center News

July 16, 2019

Fox Chase Celebrates Cancer Survivors at the Phillies

Fox Chase Cancer Center community celebrated cancer survivorship on Saturday, July 13 as the Philadelphia Phillies played the Washington Nationals.

The critical role of inflammation in cancer may be getting a bit lost, according to Sergei Grivennikov, PhD, assistant professor in the Cancer Prevention & Control Program at Fox Chase Cancer Center.
July 15, 2019

Increased Understanding of Inflammation’s Role in Cancer Should Shape Future Basic Discoveries, Clinical Trials and Drug Development

PHILADELPHIA (July 16, 2019) – Inflammation plays an instrumental role in tumor development, affecting the tumor microenvironment, immune responses, and tumor growth and spread. This critical role in cancer may be getting a bit lost.

According to Reddy, pancreatic tumors will often compress the bile ducts, obstructing bile from flowing freely. Undergoing a biliary stent procedure can alleviate the compression, allowing bile to properly drain.
July 5, 2019

Biliary Microbiome Altered After Neoadjuvant Therapy for Pancreatic Cancer

PHILADELPHIA (July 5, 2019) — The biliary microbiome was altered in patients who received neoadjuvant therapy prior to undergoing surgery for pancreatic cancer, according to new research from Fox Chase Cancer Center.

Dr. Martin was at Fox Chase Cancer Center/Temple University for a three-year fellowship in hematology/oncology, 2016-2019.
July 3, 2019

Fox Chase Cancer Center Welcomes Assistant Professor James Martin

PHILADELPHIA (July 3, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of James M. Martin, MD, who will join the faculty as assistant professor in the Hematology and Bone Marrow Transplant Programs within the Department of Hematology/Oncology.

June 28, 2019

Fox Chase Cancer Center Welcomes New Pathologist Nicholas Mackrides

PHILADELPHIA (June 28, 2019) – Fox Chase Cancer Center announces the hiring of Nicholas Mackrides, MD, who will join the faculty as a clinical instructor in the Department of Pathology.

June 27, 2019

New Kinase Nomenclature Could Aid in Design of Cancer Drug Inhibitors

PHILADELPHIA (June 27, 2019) – Researchers at Fox Chase Cancer Center have developed a new classification scheme and nomenclature for the structural states of protein kinases, which play an important role in signaling pathways and can be targeted by cancer treatments.

Josh Meyer, Radiation Oncology
June 26, 2019

Differences in Genomic Landscape of Colorectal Cancer in Younger Patients May Have Prognostic Implications

PHILADELPHIA (June 26, 2019) – Researchers at Fox Chase Cancer Center have compared the genomic landscape of CRC in younger patients to older patients. Their analysis found differences in molecular carcinogenesis and may impact treatment decision-making.

Mark Sobczak, MD, FACR
June 19, 2019

Mark Sobczak Named a 2019 Fellow of the American College of Radiology

PHILADELPHIA (June 19, 2019)— Mark Sobczak, MD, FACR, clinical director in the Department of Radiation Oncology at Fox Chase Cancer Center, was selected as a 2019 Fellow of the American College of Radiology (ACR).


Connect with Fox Chase